Many of the genes previously identified as increased within all cells from COVID-19 participants, e.g., anti-viral factors IFITM3, MX1, IFI44L, and IRF1, are upregulated among SARS-CoV-2 RNA+ cells compared to matched bystanders. This evidence concerns the gene IFI44L and COVID-19.